1	Growth	_	NN	_	_	3	NMOD	_	_
2	state-dependent	_	JJ	_	_	3	NMOD	_	_
3	regulation	_	NN	_	_	0	ROOT	_	_
4	of	_	IN	_	_	3	NMOD	_	_
5	protein	_	NN	_	_	7	NMOD	_	_
6	kinase	_	NN	_	_	7	NMOD	_	_
7	C	_	NN	_	_	4	PMOD	_	_
8	in	_	IN	_	_	3	NMOD	_	_
9	normal	_	JJ	_	_	13	NMOD	_	_
10	and	_	CC	_	_	9	COORD	_	_
11	transformed	_	JJ	_	_	10	CONJ	_	_
12	murine	_	JJ	_	_	13	NMOD	_	_
13	cells	_	NNS	_	_	8	PMOD	_	_
14	.	_	.	_	_	3	P	_	_
		
1	We	_	PRP	_	_	2	VMOD	_	_
2	determined	_	VBD	_	_	0	ROOT	_	_
3	whether	_	IN	_	_	2	VMOD	_	_
4	growth	_	NN	_	_	5	NMOD	_	_
5	state	_	NN	_	_	6	VMOD	_	_
6	can	_	MD	_	_	3	SUB	_	_
7	influence	_	VB	_	_	6	VC	_	_
8	the	_	DT	_	_	9	NMOD	_	_
9	action	_	NN	_	_	7	VMOD	_	_
10	of	_	IN	_	_	9	NMOD	_	_
11	protein	_	NN	_	_	13	NMOD	_	_
12	kinase	_	NN	_	_	13	NMOD	_	_
13	C	_	NN	_	_	10	PMOD	_	_
14	by	_	IN	_	_	7	VMOD	_	_
15	measuring	_	VBG	_	_	14	PMOD	_	_
16	protein	_	NN	_	_	18	NMOD	_	_
17	kinase	_	NN	_	_	18	NMOD	_	_
18	C	_	NN	_	_	19	NMOD	_	_
19	activity	_	NN	_	_	15	VMOD	_	_
20	in	_	IN	_	_	19	NMOD	_	_
21	growing	_	VBG	_	_	24	NMOD	_	_
22	and	_	CC	_	_	21	COORD	_	_
23	stationary	_	JJ	_	_	22	CONJ	_	_
24	cultures	_	NNS	_	_	20	PMOD	_	_
25	of	_	IN	_	_	24	NMOD	_	_
26	normal	_	JJ	_	_	29	NMOD	_	_
27	and	_	CC	_	_	26	COORD	_	_
28	transformed	_	JJ	_	_	27	CONJ	_	_
29	cells	_	NNS	_	_	25	PMOD	_	_
30	.	_	.	_	_	2	P	_	_
		
1	Two	_	CD	_	_	2	NMOD	_	_
2	approaches	_	NNS	_	_	3	VMOD	_	_
3	were	_	VBD	_	_	0	ROOT	_	_
4	used	_	VBN	_	_	3	VC	_	_
5	to	_	TO	_	_	4	VMOD	_	_
6	measure	_	VB	_	_	5	IM	_	_
7	protein	_	NN	_	_	9	NMOD	_	_
8	kinase	_	NN	_	_	9	NMOD	_	_
9	C	_	NN	_	_	6	VMOD	_	_
10	:	_	:	_	_	9	P	_	_
11	assay	_	NN	_	_	9	COORD	_	_
12	of	_	IN	_	_	11	NMOD	_	_
13	intact	_	JJ	_	_	14	NMOD	_	_
14	cells	_	NNS	_	_	12	PMOD	_	_
15	for	_	IN	_	_	11	NMOD	_	_
16	inhibition	_	NN	_	_	15	PMOD	_	_
17	of	_	IN	_	_	16	NMOD	_	_
18	epidermal	_	JJ	_	_	20	NMOD	_	_
19	growth	_	NN	_	_	20	NMOD	_	_
20	factor	_	NN	_	_	17	PMOD	_	_
21	(	_	(	_	_	22	P	_	_
22	EGF	_	NN	_	_	20	PRN	_	_
23	)	_	)	_	_	22	P	_	_
24	binding	_	VBG	_	_	20	APPO	_	_
25	in	_	IN	_	_	24	VMOD	_	_
26	response	_	NN	_	_	25	DEP	_	_
27	to	_	TO	_	_	25	DEP	_	_
28	phorbol	_	NN	_	_	29	NMOD	_	_
29	dibutyrate	_	NN	_	_	25	PMOD	_	_
30	(	_	(	_	_	31	P	_	_
31	PDBu	_	NN	_	_	29	PRN	_	_
32	)	_	)	_	_	31	P	_	_
33	;	_	:	_	_	11	P	_	_
34	and	_	CC	_	_	11	COORD	_	_
35	assay	_	NN	_	_	34	CONJ	_	_
36	of	_	IN	_	_	35	NMOD	_	_
37	detergent	_	NN	_	_	38	NMOD	_	_
38	extracts	_	NNS	_	_	36	PMOD	_	_
39	for	_	IN	_	_	35	NMOD	_	_
40	total	_	JJ	_	_	41	NMOD	_	_
41	calcium	_	NN	_	_	39	PMOD	_	_
42	,	_	,	_	_	35	P	_	_
43	phospholipid-dependent	_	JJ	_	_	45	NMOD	_	_
44	kinase	_	NN	_	_	45	NMOD	_	_
45	activity	_	NN	_	_	35	COORD	_	_
46	.	_	.	_	_	3	P	_	_
		
1	In	_	IN	_	_	19	VMOD	_	_
2	extracts	_	NNS	_	_	1	PMOD	_	_
3	of	_	IN	_	_	2	NMOD	_	_
4	growing	_	VBG	_	_	9	NMOD	_	_
5	and	_	CC	_	_	4	COORD	_	_
6	stationary	_	JJ	_	_	5	CONJ	_	_
7	Swiss	_	NN	_	_	9	NMOD	_	_
8	3T3	_	NN	_	_	9	NMOD	_	_
9	cells	_	NNS	_	_	3	PMOD	_	_
10	,	_	,	_	_	19	P	_	_
11	the	_	DT	_	_	13	NMOD	_	_
12	total	_	JJ	_	_	13	NMOD	_	_
13	amount	_	NN	_	_	19	VMOD	_	_
14	of	_	IN	_	_	13	NMOD	_	_
15	protein	_	NN	_	_	17	NMOD	_	_
16	kinase	_	NN	_	_	17	NMOD	_	_
17	C	_	NN	_	_	18	NMOD	_	_
18	activity	_	NN	_	_	14	PMOD	_	_
19	was	_	VBD	_	_	0	ROOT	_	_
20	similar	_	JJ	_	_	19	VMOD	_	_
21	,	_	,	_	_	19	P	_	_
22	indicating	_	VBG	_	_	19	VC	_	_
23	that	_	IN	_	_	22	VMOD	_	_
24	growth	_	NN	_	_	25	NMOD	_	_
25	state	_	NN	_	_	26	VMOD	_	_
26	does	_	VBZ	_	_	23	SUB	_	_
27	not	_	RB	_	_	26	VMOD	_	_
28	alter	_	VB	_	_	26	VC	_	_
29	the	_	DT	_	_	30	NMOD	_	_
30	level	_	NN	_	_	28	VMOD	_	_
31	of	_	IN	_	_	30	NMOD	_	_
32	enzyme	_	NN	_	_	31	PMOD	_	_
33	in	_	IN	_	_	30	NMOD	_	_
34	the	_	DT	_	_	35	NMOD	_	_
35	cell	_	NN	_	_	33	PMOD	_	_
36	.	_	.	_	_	19	P	_	_
		
1	The	_	DT	_	_	3	NMOD	_	_
2	short-term	_	JJ	_	_	3	NMOD	_	_
3	response	_	NN	_	_	16	VMOD	_	_
4	of	_	IN	_	_	3	NMOD	_	_
5	Swiss	_	NN	_	_	7	NMOD	_	_
6	3T3	_	NN	_	_	7	NMOD	_	_
7	cells	_	NNS	_	_	4	PMOD	_	_
8	to	_	TO	_	_	3	NMOD	_	_
9	an	_	DT	_	_	10	NMOD	_	_
10	activator	_	NN	_	_	8	PMOD	_	_
11	of	_	IN	_	_	10	NMOD	_	_
12	protein	_	NN	_	_	14	NMOD	_	_
13	kinase	_	NN	_	_	14	NMOD	_	_
14	C	_	NN	_	_	11	PMOD	_	_
15	also	_	RB	_	_	16	VMOD	_	_
16	appeared	_	VBD	_	_	0	ROOT	_	_
17	to	_	TO	_	_	16	VMOD	_	_
18	be	_	VB	_	_	17	IM	_	_
19	independent	_	JJ	_	_	18	VMOD	_	_
20	of	_	IN	_	_	19	AMOD	_	_
21	growth	_	NN	_	_	22	NMOD	_	_
22	state	_	NN	_	_	20	PMOD	_	_
23	,	_	,	_	_	16	P	_	_
24	since	_	IN	_	_	16	VMOD	_	_
25	the	_	DT	_	_	29	NMOD	_	_
26	50	_	CD	_	_	27	AMOD	_	_
27	%	_	NN	_	_	29	NMOD	_	_
28	effective	_	JJ	_	_	29	NMOD	_	_
29	dose	_	NN	_	_	39	VMOD	_	_
30	for	_	IN	_	_	29	NMOD	_	_
31	PDBu	_	NN	_	_	32	NMOD	_	_
32	inhibition	_	NN	_	_	30	PMOD	_	_
33	of	_	IN	_	_	32	NMOD	_	_
34	EGF	_	NN	_	_	35	NMOD	_	_
35	binding	_	NN	_	_	33	PMOD	_	_
36	to	_	TO	_	_	35	NMOD	_	_
37	its	_	PRP$	_	_	38	NMOD	_	_
38	receptor	_	NN	_	_	36	PMOD	_	_
39	was	_	VBD	_	_	24	SUB	_	_
40	approximately	_	RB	_	_	42	NMOD	_	_
41	7	_	CD	_	_	40	DEP	_	_
42	nM	_	NN	_	_	39	VMOD	_	_
43	for	_	IN	_	_	39	VMOD	_	_
44	both	_	DT	_	_	46	NMOD	_	_
45	growth	_	NN	_	_	46	NMOD	_	_
46	conditions	_	NNS	_	_	43	PMOD	_	_
47	.	_	.	_	_	16	P	_	_
		
1	In	_	IN	_	_	13	VMOD	_	_
2	contrast	_	NN	_	_	1	PMOD	_	_
3	,	_	,	_	_	13	P	_	_
4	the	_	DT	_	_	5	NMOD	_	_
5	response	_	NN	_	_	13	VMOD	_	_
6	of	_	IN	_	_	5	NMOD	_	_
7	cells	_	NNS	_	_	6	PMOD	_	_
8	to	_	TO	_	_	5	NMOD	_	_
9	long-term	_	JJ	_	_	10	NMOD	_	_
10	treatment	_	NN	_	_	8	PMOD	_	_
11	with	_	IN	_	_	10	NMOD	_	_
12	PDBu	_	NN	_	_	11	PMOD	_	_
13	was	_	VBD	_	_	0	ROOT	_	_
14	significantly	_	RB	_	_	15	AMOD	_	_
15	different	_	JJ	_	_	13	VMOD	_	_
16	depending	_	VBG	_	_	15	AMOD	_	_
17	upon	_	IN	_	_	16	PMOD	_	_
18	the	_	DT	_	_	21	NMOD	_	_
19	initial	_	JJ	_	_	21	NMOD	_	_
20	growth	_	NN	_	_	21	NMOD	_	_
21	state	_	NN	_	_	17	PMOD	_	_
22	of	_	IN	_	_	21	NMOD	_	_
23	the	_	DT	_	_	24	NMOD	_	_
24	cells	_	NNS	_	_	22	PMOD	_	_
25	.	_	.	_	_	13	P	_	_
		
1	In	_	IN	_	_	7	VMOD	_	_
2	both	_	DT	_	_	4	NMOD	_	_
3	growth	_	NN	_	_	4	NMOD	_	_
4	states	_	NNS	_	_	1	PMOD	_	_
5	,	_	,	_	_	7	P	_	_
6	PDBu	_	NN	_	_	7	VMOD	_	_
7	caused	_	VBD	_	_	0	ROOT	_	_
8	loss	_	NN	_	_	7	VMOD	_	_
9	of	_	IN	_	_	8	NMOD	_	_
10	protein	_	NN	_	_	12	NMOD	_	_
11	kinase	_	NN	_	_	12	NMOD	_	_
12	C	_	NN	_	_	13	NMOD	_	_
13	activity	_	NN	_	_	9	PMOD	_	_
14	,	_	,	_	_	8	P	_	_
15	which	_	WDT	_	_	16	VMOD	_	_
16	reflected	_	VBD	_	_	8	NMOD	_	_
17	a	_	DT	_	_	18	NMOD	_	_
18	loss	_	NN	_	_	16	VMOD	_	_
19	in	_	IN	_	_	18	NMOD	_	_
20	protein	_	NN	_	_	21	NMOD	_	_
21	mass	_	NN	_	_	19	PMOD	_	_
22	as	_	IN	_	_	16	VMOD	_	_
23	determined	_	VBN	_	_	22	SUB	_	_
24	by	_	IN	_	_	23	VMOD	_	_
25	immunoblotting	_	VBG	_	_	24	PMOD	_	_
26	with	_	IN	_	_	25	VMOD	_	_
27	antiserum	_	NN	_	_	26	PMOD	_	_
28	to	_	TO	_	_	27	NMOD	_	_
29	protein	_	NN	_	_	31	NMOD	_	_
30	kinase	_	NN	_	_	31	NMOD	_	_
31	C	_	NN	_	_	28	PMOD	_	_
32	.	_	.	_	_	7	P	_	_
		
1	However	_	RB	_	_	6	VMOD	_	_
2	,	_	,	_	_	6	P	_	_
3	the	_	DT	_	_	5	NMOD	_	_
4	maximum	_	JJ	_	_	5	NMOD	_	_
5	decrease	_	NN	_	_	6	VMOD	_	_
6	approached	_	VBD	_	_	0	ROOT	_	_
7	100	_	CD	_	_	8	NMOD	_	_
8	%	_	NN	_	_	6	VMOD	_	_
9	in	_	IN	_	_	8	NMOD	_	_
10	stationary	_	JJ	_	_	11	NMOD	_	_
11	cultures	_	NNS	_	_	9	PMOD	_	_
12	versus	_	CC	_	_	8	COORD	_	_
13	approximately	_	RB	_	_	15	NMOD	_	_
14	75	_	CD	_	_	13	DEP	_	_
15	%	_	NN	_	_	12	CONJ	_	_
16	in	_	IN	_	_	15	NMOD	_	_
17	growing	_	VBG	_	_	18	NMOD	_	_
18	cells	_	NNS	_	_	16	PMOD	_	_
19	.	_	.	_	_	6	P	_	_
		
1	Protein	_	NN	_	_	3	NMOD	_	_
2	kinase	_	NN	_	_	3	NMOD	_	_
3	C	_	NN	_	_	4	NMOD	_	_
4	levels	_	NNS	_	_	10	VMOD	_	_
5	in	_	IN	_	_	4	NMOD	_	_
6	several	_	JJ	_	_	9	NMOD	_	_
7	transformed	_	JJ	_	_	9	NMOD	_	_
8	cell	_	NN	_	_	9	NMOD	_	_
9	lines	_	NNS	_	_	5	PMOD	_	_
10	were	_	VBD	_	_	0	ROOT	_	_
11	subject	_	JJ	_	_	10	VMOD	_	_
12	to	_	TO	_	_	11	AMOD	_	_
13	down	_	NN	_	_	14	NMOD	_	_
14	modulation	_	NN	_	_	12	PMOD	_	_
15	in	_	IN	_	_	10	VMOD	_	_
16	a	_	DT	_	_	20	NMOD	_	_
17	similar	_	JJ	_	_	20	NMOD	_	_
18	growth	_	NN	_	_	20	NMOD	_	_
19	state-dependent	_	JJ	_	_	20	NMOD	_	_
20	manner	_	NN	_	_	15	PMOD	_	_
21	.	_	.	_	_	10	P	_	_
		
1	Further	_	RB	_	_	21	VMOD	_	_
2	,	_	,	_	_	21	P	_	_
3	the	_	DT	_	_	4	NMOD	_	_
4	inhibition	_	NN	_	_	21	VMOD	_	_
5	of	_	IN	_	_	4	NMOD	_	_
6	EGF	_	NN	_	_	7	NMOD	_	_
7	binding	_	NN	_	_	5	PMOD	_	_
8	by	_	IN	_	_	4	NMOD	_	_
9	tumor	_	NN	_	_	10	NMOD	_	_
10	promoters	_	NNS	_	_	8	PMOD	_	_
11	following	_	VBG	_	_	10	NMOD	_	_
12	long-term	_	JJ	_	_	13	NMOD	_	_
13	treatment	_	NN	_	_	11	PMOD	_	_
14	of	_	IN	_	_	13	NMOD	_	_
15	Swiss	_	NN	_	_	17	NMOD	_	_
16	3T3	_	NN	_	_	17	NMOD	_	_
17	cells	_	NNS	_	_	14	PMOD	_	_
18	with	_	IN	_	_	13	NMOD	_	_
19	PDBu	_	NN	_	_	18	PMOD	_	_
20	also	_	RB	_	_	21	VMOD	_	_
21	varied	_	VBD	_	_	0	ROOT	_	_
22	with	_	IN	_	_	21	VMOD	_	_
23	growth	_	NN	_	_	24	NMOD	_	_
24	state	_	NN	_	_	22	PMOD	_	_
25	.	_	.	_	_	21	P	_	_
		
1	In	_	IN	_	_	8	VMOD	_	_
2	down	_	RB	_	_	3	AMOD	_	_
3	modulated	_	VBN	_	_	5	NMOD	_	_
4	growing	_	VBG	_	_	5	NMOD	_	_
5	cells	_	NNS	_	_	1	PMOD	_	_
6	,	_	,	_	_	8	P	_	_
7	PDBu	_	NN	_	_	8	VMOD	_	_
8	caused	_	VBD	_	_	0	ROOT	_	_
9	almost	_	RB	_	_	10	AMOD	_	_
10	complete	_	JJ	_	_	11	NMOD	_	_
11	inhibition	_	NN	_	_	8	VMOD	_	_
12	of	_	IN	_	_	11	NMOD	_	_
13	EGF	_	NN	_	_	14	NMOD	_	_
14	binding	_	NN	_	_	12	PMOD	_	_
15	,	_	,	_	_	8	P	_	_
16	whereas	_	IN	_	_	8	VMOD	_	_
17	in	_	IN	_	_	30	VMOD	_	_
18	down	_	RB	_	_	19	AMOD	_	_
19	modulated	_	VBN	_	_	21	NMOD	_	_
20	stationary	_	JJ	_	_	21	NMOD	_	_
21	cells	_	NNS	_	_	17	PMOD	_	_
22	,	_	,	_	_	30	P	_	_
23	minimal	_	JJ	_	_	24	NMOD	_	_
24	inhibition	_	NN	_	_	30	VMOD	_	_
25	of	_	IN	_	_	24	NMOD	_	_
26	EGF	_	NN	_	_	27	NMOD	_	_
27	binding	_	NN	_	_	25	PMOD	_	_
28	by	_	IN	_	_	24	NMOD	_	_
29	PDBu	_	NN	_	_	28	PMOD	_	_
30	was	_	VBD	_	_	16	SUB	_	_
31	observed	_	VBN	_	_	30	VC	_	_
32	.	_	.	_	_	8	P	_	_
		
1	These	_	DT	_	_	2	NMOD	_	_
2	results	_	NNS	_	_	3	VMOD	_	_
3	suggest	_	VBP	_	_	0	ROOT	_	_
4	that	_	IN	_	_	3	VMOD	_	_
5	prolonged	_	JJ	_	_	6	NMOD	_	_
6	treatment	_	NN	_	_	10	VMOD	_	_
7	with	_	IN	_	_	6	NMOD	_	_
8	tumor	_	NN	_	_	9	NMOD	_	_
9	promoters	_	NNS	_	_	7	PMOD	_	_
10	alters	_	VBZ	_	_	4	SUB	_	_
11	the	_	DT	_	_	12	NMOD	_	_
12	sensitivity	_	NN	_	_	10	VMOD	_	_
13	of	_	IN	_	_	12	NMOD	_	_
14	cells	_	NNS	_	_	13	PMOD	_	_
15	to	_	TO	_	_	12	NMOD	_	_
16	activators	_	NNS	_	_	15	PMOD	_	_
17	of	_	IN	_	_	16	NMOD	_	_
18	protein	_	NN	_	_	20	NMOD	_	_
19	kinase	_	NN	_	_	20	NMOD	_	_
20	C	_	NN	_	_	17	PMOD	_	_
21	in	_	IN	_	_	10	VMOD	_	_
22	a	_	DT	_	_	25	NMOD	_	_
23	growth	_	NN	_	_	25	NMOD	_	_
24	state-dependent	_	JJ	_	_	25	NMOD	_	_
25	manner	_	NN	_	_	21	PMOD	_	_
26	.	_	.	_	_	3	P	_	_
		
